Brain Cancer Trial, Recruiting NCT04699773 Sponsor: University of Maryland, Baltimore Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT04699773
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have brain scan (imaging) results that suggest you may have a fast-growing brain tumor called a high-grade glioma
  • A recent MRI scan with contrast dye (taken within the last 60 days) shows a tumor mass, and a neurosurgeon has confirmed you are a suitable candidate for a laser treatment procedure called LITT
  • You have had a full physical and neurological (nervous system) check-up within the last 30 days
  • You are able to carry out basic daily activities and care for yourself to a reasonable degree, as assessed by your doctor within the last 30 days
  • You are 18 years of age or older
  • You have read and signed a consent form agreeing to take part in the study
  • If you could become pregnant or get a partner pregnant, you agree to use effective birth control during the study and for 6 months after it ends
  • If you are a woman who could become pregnant, you have had a negative pregnancy test within the last 28 days

Who may not be able to join:

  • You are not considered medically suitable for a stereotactic biopsy (a type of brain tissue sample procedure) or laser ablation surgery
  • You have serious heart problems, including uncontrolled irregular heartbeats, or have had a heart attack, severe chest pain, heart bypass surgery, heart failure, stroke, mini-stroke, or a blood clot in the lungs within the last 6 months
  • Your tumor is located in the lower part of the brain (below a structure called the tentorium) or has spread to the lining of the brain or spinal cord
  • You are unable to have an MRI scan for any reason
  • You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 February 2021
Est. completion
1 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov